Bimatoprost-Mepha Plus, Augentropfen

7680669760021 CH-66976 Augentropfen

Associated product:

Bimatoprost-Mepha Plus, gtt opht , 3 fl 3 ml
Bimatoprost-Mepha Plus, Augentropfen
Bimatoprost-Mepha Plus, Augentropfen
Bimatoprost-Mepha Plus, Augentropfen
1 / 3
google

Article details

Package size
3 x 3
Selling units
3
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/07/2023
Patient information leaflet
Français
12/07/2023
Patient information leaflet
Italien
12/07/2023
Summary of Product Characteristics
Allemand
12/07/2023
Summary of Product Characteristics
Français
12/07/2023
Summary of Product Characteristics
Italien
12/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.3 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance Konservierungsstoff (Conservateur)

Reimbursement information

Public price
CHF 63.40
Specialties list
Yes
Generic
Yes
SL addition date: 01/06/2022

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66976
Drug name
Bimatoprost-Mepha Plus, Augentropfenlösung
Galenic form
AUGT
ATC Code
S01ED51
Authorization status
Z
Dispensing category
B
First authorization
03/10/2018
Authorization expiration date
31/12/9999
IT Number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Package details

Description (FR)
BIMATOPROST Mepha Plus gtt opht 3 fl 3 ml
Description (DE)
BIMATOPROST Mepha Plus Gtt Opht 3 Fl 3 ml
Market launch
03/10/2018
Market withdrawal
25/06/2025
Narcotic (BTM)
No

Original drug

Azarga, Augentropfensuspension
GTIN: 7680591790011
CHF 30.70
View original

Other package sizes (1)

BIMATOPROST Mepha Plus gtt opht fl 3 ml
3 ML
GTIN: 7680669760014
View